Iris Kopeloff

435 total citations · 1 hit paper
6 papers, 374 citations indexed

About

Iris Kopeloff is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Iris Kopeloff has authored 6 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 2 papers in Pathology and Forensic Medicine and 2 papers in Oncology. Recurrent topics in Iris Kopeloff's work include T-cell and B-cell Immunology (2 papers), Immunotherapy and Immune Responses (2 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). Iris Kopeloff is often cited by papers focused on T-cell and B-cell Immunology (2 papers), Immunotherapy and Immune Responses (2 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). Iris Kopeloff collaborates with scholars based in United States, Australia and India. Iris Kopeloff's co-authors include Ralph M. Steinman, Una O’Doherty, William J. Swiggard, Nina Bhardwaj, Paul Cameron, Melissa Pope, Michael Peng, Stuart Gezelter, Seth J. Orlow and S. Meehan and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of the American Academy of Dermatology and Advances in experimental medicine and biology.

In The Last Decade

Iris Kopeloff

5 papers receiving 359 citations

Hit Papers

Dendritic cells freshly isolated from human blood express... 1993 2026 2004 2015 1993 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris Kopeloff United States 5 321 61 44 38 27 6 374
Jonathan Dixey United Kingdom 10 147 0.5× 63 1.0× 31 0.7× 30 0.8× 10 0.4× 15 304
Penelope A. Bedford United Kingdom 9 277 0.9× 68 1.1× 15 0.3× 39 1.0× 45 1.7× 14 351
Carolyn E. Rydyznski United States 6 278 0.9× 35 0.6× 40 0.9× 33 0.9× 56 2.1× 9 370
C. Kinet-Denoël Belgium 13 476 1.5× 54 0.9× 36 0.8× 50 1.3× 25 0.9× 32 579
A Rivas United States 10 372 1.2× 68 1.1× 52 1.2× 59 1.6× 30 1.1× 13 433
Marie‐Hélène Donnadieu France 4 305 1.0× 67 1.1× 12 0.3× 61 1.6× 13 0.5× 4 358
Theres Oakes United Kingdom 9 326 1.0× 140 2.3× 33 0.8× 117 3.1× 39 1.4× 12 435
Douglas S. Smoot United States 8 320 1.0× 85 1.4× 17 0.4× 60 1.6× 21 0.8× 8 404
J. Rafael Argüello United Kingdom 8 256 0.8× 39 0.6× 30 0.7× 30 0.8× 21 0.8× 12 334
Salah Eddine Bentebibel United States 6 393 1.2× 41 0.7× 18 0.4× 83 2.2× 32 1.2× 7 440

Countries citing papers authored by Iris Kopeloff

Since Specialization
Citations

This map shows the geographic impact of Iris Kopeloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Kopeloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Kopeloff more than expected).

Fields of papers citing papers by Iris Kopeloff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Kopeloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Kopeloff. The network helps show where Iris Kopeloff may publish in the future.

Co-authorship network of co-authors of Iris Kopeloff

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Kopeloff. A scholar is included among the top collaborators of Iris Kopeloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Kopeloff. Iris Kopeloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Gebauer, Kurt, Lynda Spelman, Paul S. Yamauchi, et al.. (2024). Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study. Journal of the American Academy of Dermatology. 91(1). 91–99. 6 indexed citations
2.
Sofen, Howard, Kurt Gebauer, Lynda Spelman, et al.. (2024). Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 92(4). 816–824.
3.
Criscito, Maressa C., Euphemia W. Mu, S. Meehan, David Polsky, & Iris Kopeloff. (2017). Dermoscopic features of a solitary fibrofolliculoma on the left cheek. Journal of the American Academy of Dermatology. 76(2). S8–S9. 5 indexed citations
4.
O’Doherty, Una, Ralph M. Steinman, Michael Peng, et al.. (1993). Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium.. The Journal of Experimental Medicine. 178(3). 1067–1076. 345 indexed citations breakdown →
5.
O’Doherty, Una, William J. Swiggard, Yasunori Yamaguchi, et al.. (1993). Tolerizing Mice to Human Leukocytes: A Step Toward the Production of Monoclonal Antibodies Specific for Human Dendritic Cells. Advances in experimental medicine and biology. 329. 165–172. 6 indexed citations
6.
Kopeloff, Iris, et al.. (1992). Multiple pilomatricomas: report of two cases and review of the association with myotonic dystrophy.. PubMed. 50(4). 290–2. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026